Company filings profile · CIK 0001728328

InMed Pharmaceuticals Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for InMed Pharmaceuticals Inc. (INM): 16 filings in the last 90 days vs 20 in the prior 90 (filing-velocity cooling ↓ · 0.8×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Sep 19, 2026. Source-linked, daily-refreshed.

Material 8-K events — InMed Pharmaceuticals Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Sep 18, 2026Delisting / Listing-Rule Failure; Other Events; Financial Statements and Exhibits
Jul 22, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
Jul 10, 2026Entry into a Material Agreement; Regulation FD Disclosure; Financial Statements and Exhibits
Jun 10, 2026Other Events; Financial Statements and Exhibits
May 19, 2026Entry into a Material Agreement; Change in Control; Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits
May 19, 2026Entry into a Material Agreement; Item 3.03; Other Events; Financial Statements and Exhibits
May 7, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Apr 27, 2026Entry into a Material Agreement; Item 3.03; Other Events; Financial Statements and Exhibits
Apr 3, 2026Other Events; Financial Statements and Exhibits
Mar 30, 2026Delisting / Listing-Rule Failure; Financial Statements and Exhibits
Mar 23, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Mar 9, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Mar 6, 2026Costs of Exit/Disposal Activities; Regulation FD Disclosure; Financial Statements and Exhibits

Watch InMed Pharmaceuticals Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
Sep 16, 20264
Jul 17, 20264
Jul 16, 20264
Jul 2, 20264
Jun 10, 20264
Jun 10, 20263
May 21, 20264
May 21, 20263
Dec 19, 20254
Dec 19, 20254
Dec 19, 20254
Dec 19, 20254
Dec 19, 20254
Dec 19, 20254
Dec 19, 20254
Dec 19, 20254
Dec 19, 20254
Dec 17, 20254
Dec 17, 20254
Dec 17, 20254

Recent filings

FiledFormDetail
Sep 18, 20268-K Delisting / Listing-Rule Failure; Other Events; Financial Statements and Exhibits
Sep 16, 20264 PRIMARY DOCUMENT
Sep 9, 2026S-4/A S-4/A
Sep 9, 2026425 FORM 425
Sep 9, 202610-K ANNUAL REPORT
Aug 14, 2026SCHEDULE 13G
Jul 22, 2026425 FORM 425
Jul 22, 2026425 CURRENT REPORT
Jul 22, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
Jul 20, 2026425 FORM 425
Jul 17, 20264 PRIMARY DOCUMENT
Jul 16, 20264
Jul 10, 2026425 CURRENT REPORT
Jul 10, 20268-K Entry into a Material Agreement; Regulation FD Disclosure; Financial Statements and Exhibits
Jul 2, 20264
Jul 2, 2026S-4 S-4
Jun 10, 2026SCHEDULE 13D
Jun 10, 20264
Jun 10, 20263
Jun 10, 20268-K Other Events; Financial Statements and Exhibits
Jun 5, 2026SCHEDULE 13G
May 27, 2026SCHEDULE 13G
May 21, 20264 PRIMARY DOCUMENT
May 21, 20263 PRIMARY DOCUMENT
May 19, 2026425 CURRENT REPORT
May 19, 20268-K Entry into a Material Agreement; Change in Control; Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits
May 19, 20268-K Entry into a Material Agreement; Item 3.03; Other Events; Financial Statements and Exhibits
May 7, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
May 6, 202610-Q QUARTERLY REPORT
Apr 27, 20268-K Entry into a Material Agreement; Item 3.03; Other Events; Financial Statements and Exhibits
Apr 3, 20268-K Other Events; Financial Statements and Exhibits
Apr 3, 2026424B5 PROSPECTUS SUPPLEMENT
Mar 30, 2026EFFECT Item ; Item ; Item
Mar 30, 20268-K Delisting / Listing-Rule Failure; Financial Statements and Exhibits
Mar 26, 2026CORRESP
Mar 25, 2026UPLOAD
Mar 23, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Mar 20, 2026S-3 REGISTRATION STATEMENT
Mar 9, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Mar 6, 20268-K Costs of Exit/Disposal Activities; Regulation FD Disclosure; Financial Statements and Exhibits